Treatment of autoimmune disorders with a neurotoxin

Details for Australian Patent Application No. 2006259728 (hide)

Owner Allergan, Inc.

Inventors Van Schaack, Pamela D.; Tong, Kenneth L.

Agent Davies Collison Cave

Pub. Number AU-B-2006259728

PCT Pub. Number WO2006/138059

Priority 11/156,502 17.06.05 US

Filing date 31 May 2006

Wipo publication date 28 December 2006

Acceptance publication date 10 November 2011

International Classifications

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/138059 Priority application(s): WO2006/138059

10 November 2011 Application Accepted

  Published as AU-B-2006259728

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259730-Method and apparatus for gaming vouchering system

2006259709-Plastic conveyor belts and modules with lateral channels